Physician profile
David Ewart
NPI 1659331924
$3,555.31
in general payments reported to CMS, 2019-2025
38 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.69 · 2020: $125 · 2021: $95.36 · 2022: $162 · 2023: $936 · 2024: $1,144 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,100.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $565.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $423.41 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $341.77 | 2019-2025 | |
| Amgen INC. | $312.04 | 2020-2025 | Evenity, Otezla, Repatha |
| Abbvie INC. | $272.31 | 2023-2025 | |
| Glaxosmithkline, LLC. | $152.20 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $128.11 | 2023-2025 | Gemtesa |
| Eisai INC. | $119.34 | 2020-2025 | |
| Radius Health, INC. | $116.51 | 2024-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.71 | 2023-2024 | Jardiance, Synjardy, Tradjenta |
| Ardelyx, INC. | $104.50 | 2024-2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $96.58 | 2023-2025 | Airsupra, Breztri |
| Boston Scientific Corporation | $68.01 | 2024-2025 | Watchman Flx |
| Astellas Pharma US INC | $60.22 | 2023-2025 | Veozah, Myrbetriq |
| Xeris Pharmaceuticals, INC. | $60.13 | 2022-2024 | Keveyis, Gvoke Hypopen |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.58 | 2023-2025 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $56.28 | 2025 | Voquezna |
| Exact Sciences Corporation | $55.91 | 2023-2024 | Cologuard Collection Kit |
| Globus Medical, INC. | $52.04 | 2025 | Senza |
| Abbott Laboratories | $41.30 | 2022-2024 | Proclaim |
| Cequr Corporation | $39.81 | 2023-2024 | Cequr Simplicity |
| Dexcom, INC. | $34.89 | 2024 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $30.65 | 2024 | Nexletol |
| Merz Pharmaceuticals, LLC | $25.25 | 2025 | Xeomin |
| Spinal Simplicity, LLC | $24.46 | 2025 | Ha Minuteman G3-R |
| Vital Connect, INC | $21.30 | 2025 | Vitalpatch Rtm |
| Dynavax Technologies Corporation | $19.65 | 2024 | Heplisav-B |
| Depuy Synthes Sales INC. | $17.69 | 2023 | Orthovisc, Peak, Monovisc |
| Novartis Pharmaceuticals Corporation | $17.55 | 2019 | |
| Corcept Therapeutics | $17.33 | 2023 | Korlym |
| Teleflex LLC | $17.14 | 2024 | Urolift |
| Mylan Specialty L.P. | $16.52 | 2020 | |
| Shield Therapeutics INC | $16.12 | 2023 | Accrufer |
| Ibsa Pharma INC. | $14.42 | 2025 | Flector, Tirosint, Licart |
| E.R. Squibb & Sons, L.L.C. | $13.03 | 2023 | |
| Almatica Pharma LLC | $12.69 | 2021 | |
| Merck Sharp & Dohme LLC | $12.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.